Market Place
Sourcing Support
Novartis India Posts Q2 FY26 PAT At Rs. 24.22 Cr
30 Oct 2025 //
INDPHARMAPOST
Novartis Unveils Data On First Targeted Sjögren`s Treatment
29 Oct 2025 //
BIOSPACE
Novartis` Phase 3 Wins In Sjögren`s See High Placebo Effect
29 Oct 2025 //
FIERCE BIOTECH
Novartis CEO Criticizes Trump`s Drug Pricing Deals
28 Oct 2025 //
BIOSPACE
Novartis Reports Strong Q3; Sales Growth And Pipeline Progress
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Announces Expiration Of Tourmaline Bio Tender Offer
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Acquisition Of Tourmaline Bio
28 Oct 2025 //
GLOBENEWSWIRE
Newer Drugs Came To Novartis` Aid As 2 Top-Selling Brands Stalled
28 Oct 2025 //
FIERCE PHARMA
Novartis Bolsters Neuromuscular Pipeline Via $12B Avidity Buyout
27 Oct 2025 //
BIOSPACE
Novartis Presents Immunology Breakthroughs At ACR Congress
25 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Hart-Scott-Rodino Waiting Period
22 Oct 2025 //
GLOBENEWSWIRE
Novartis` Cosentyx® Succeeds In Phase III Trial For PMR
22 Oct 2025 //
GLOBENEWSWIRE
Novartis Sues Az`s Alexion Over `Misleading` Ultomiris Marketing
22 Oct 2025 //
FIERCE PHARMA
Arrowhead Pharma Finalizes Global Collaboration Deal
21 Oct 2025 //
BUSINESSWIRE
Novartis` Pluvicto Slows Progression In Earlier Prostate Cancer
19 Oct 2025 //
FIERCE PHARMA
Novartis` Scemblix® Gets Positive CHMP Opinion For Newly CML
17 Oct 2025 //
GLOBENEWSWIRE
Novartis Kisqali Cuts Recurrence Risk by 28% in NATALEE Data
17 Oct 2025 //
GLOBENEWSWIRE
Novartis` Fabhalta Slows Kidney Decline In Iga Nephropathy
16 Oct 2025 //
GLOBENEWSWIRE
Novartis Survey Explores Women`s Feelings About Breast Health
07 Oct 2025 //
FIERCE PHARMA
Novartis` Skin Disease Drug Gets Us Approval
01 Oct 2025 //
REUTERS
Novartis Earns FDA Ire For `misleading` Fabhalta Ad Imagery
30 Sep 2025 //
FIERCE PHARMA
Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices
29 Sep 2025 //
FIERCE PHARMA
Novartis Initiates Tender Offer For Tourmaline Bio Acquisition
29 Sep 2025 //
GLOBENEWSWIRE
Novartis Launches Direct-To-Patient Platform For Cosentyx In US
29 Sep 2025 //
GLOBENEWSWIRE
Novartis To Present Breakthrough Data On Prostate & Breast Cancer
26 Sep 2025 //
GLOBENEWSWIRE
Novartis Data Support Kesimpta In Relapsing MS After Oral Switch
24 Sep 2025 //
GLOBENEWSWIRE
Novartis Seeks Solutions To Lower Us Bring Down Drug Costs in US
22 Sep 2025 //
BIOSPACE
Eckert & Ziegler Gets Approval for GalliaPharm in Japan
19 Sep 2025 //
PHARMAWEB
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
India Revokes Patent of Novartis` Blockbuster Cardiac Drug
16 Sep 2025 //
ECONOMICTIMES
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
Novartis Signs up to $5.7 B licensing deal with Monte Rosa
15 Sep 2025 //
REUTERS
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
Novartis to Acquire Tourmaline Bio for $1.4 Billion
09 Sep 2025 //
REUTERS
NRG Secures £50M Series B Funding for Parkinson`s Research
08 Sep 2025 //
GLOBENEWSWIRE
Novartis Signs up To $5.2 B Deal with China`s Biotech Argo
04 Sep 2025 //
REUTERS
Arrowhead, Novartis in Up to $2B Deal for Neuromuscular Therapy
03 Sep 2025 //
REUTERS
Novartis Plans 58 Layoffs in N.J.
02 Sep 2025 //
FIERCE PHARMA
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
01 Sep 2025 //
BUSINESSWIRE
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
29 Aug 2025 //
BIOSPACE
BioArctic: Interim Report for the period April - June 2025
28 Aug 2025 //
PR NEWSWIRE
Lilly Answers Novartis Breast Cancer Rivalry with Survival Win
27 Aug 2025 //
FIERCE PHARMA
Novartis pens BioArctic neuro pact worth $30M upfront
27 Aug 2025 //
FIERCE BIOTECH
Novartis, BioArctic Partner on BrainTransporter for Neurology
26 Aug 2025 //
EXPRESSPHARMA
Novartis ESC Data Showcases Cardiovascular Portfolio Strength
18 Aug 2025 //
GLOBENEWSWIRE
Novartis Scores Double Phase 3 Win in Sjögren`s Syndrome
12 Aug 2025 //
FIERCE BIOTECH
Novartis Weighs Deal for Biotech Avidity Biosciences
09 Aug 2025 //
REUTERS
Novartis Hunts New Assets, Rumored Takeover of RNA Specialist
07 Aug 2025 //
BIOSPACE
FDA Approves Novartis` Leqvio (Inclisiran) for First-Line Use
31 Jul 2025 //
PR NEWSWIRE
Novartis India Reports Rs. 27.62 Cr Net Profit in Q1 FY26
30 Jul 2025 //
INDPHARMAPOST
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
26 Jul 2025 //
GLOBENEWSWIRE
Analysis Group Explores HEOR Use in Rare Disease CGTs
22 Jul 2025 //
PR NEWSWIRE
Novartis Speeds up Us Manufacturing of Key Drugs as Tariffs
18 Jul 2025 //
BIOSPACE
Novartis` Pluvicto Picks up Speed, Delivers Another Trial Win
17 Jul 2025 //
FIERCE PHARMA
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Names Mukul Mehta CFO as Harry Kirsch Retires
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
US Entresto Generic Unblocked as Novartis Loses Bid till 2026
11 Jul 2025 //
REUTERS
Novartis inks $175M option deal for Sironax’s blood-brain barrier
10 Jul 2025 //
PR NEWSWIRE
Novartis` Malaria Drug for Babies Gets First Global Approval
08 Jul 2025 //
FIERCE PHARMA
